These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27039817)

  • 21. Serum TEM5 and TEM7 concentrations correlate with clinicopathologic features and poor prognosis of colorectal cancer patients.
    Pietrzyk Ł; Wdowiak P
    Adv Med Sci; 2019 Sep; 64(2):402-408. PubMed ID: 31352222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Application of Serum Tumor Abnormal Protein (TAP) in Colorectal Cancer Patients.
    Wu XY; Huang XE
    Asian Pac J Cancer Prev; 2015; 16(8):3425-8. PubMed ID: 25921156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biomarkers Apo10 and TKTL1: Epitope-detection in monocytes (EDIM) as a new diagnostic approach for cholangiocellular, pancreatic and colorectal carcinoma.
    Saman S; Stagno MJ; Warmann SW; Malek NP; Plentz RR; Schmid E
    Cancer Biomark; 2020; 27(1):129-137. PubMed ID: 31771043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth/differentiation factor 15 (GDF-15) as new potential serum marker in patients with metastatic colorectal cancer.
    Vocka M; Langer D; Fryba V; Petrtyl J; Hanus T; Kalousova M; Zima T; Petruzelka L
    Cancer Biomark; 2018; 21(4):869-874. PubMed ID: 29400662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating miR-338-5p is a potential diagnostic biomarker in colorectal cancer.
    Bilegsaikhan E; Liu HN; Shen XZ; Liu TT
    J Dig Dis; 2018 Jul; 19(7):404-410. PubMed ID: 29952077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can preoperative CEA and CA19-9 serum concentrations suggest metastatic disease in colorectal cancer patients?
    Stojkovic Lalosevic M; Stankovic S; Stojkovic M; Markovic V; Dimitrijevic I; Lalosevic J; Petrovic J; Brankovic M; Pavlovic Markovic A; Krivokapic Z
    Hell J Nucl Med; 2017; 20(1):41-45. PubMed ID: 28315907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating tumour markers can define patients with normal colons, benign polyps, and cancers.
    Mead R; Duku M; Bhandari P; Cree IA
    Br J Cancer; 2011 Jul; 105(2):239-45. PubMed ID: 21712823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum carbohydrate antigen 19-9 as an indicator of liver metastasis in colorectal carcinoma cases.
    Dong H; Tang J; Li LH; Ge J; Chen X; Ding J; Men HT; Luo WX; Du Y; Li C; Zhao F; Chen Y; Cheng K; Liu JY
    Asian Pac J Cancer Prev; 2013; 14(2):909-13. PubMed ID: 23621260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic and prognostic role of cell-free DNA testing for colorectal cancer patients.
    Bedin C; Enzo MV; Del Bianco P; Pucciarelli S; Nitti D; Agostini M
    Int J Cancer; 2017 Apr; 140(8):1888-1898. PubMed ID: 27943272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum leucine-rich alpha-2-glycoprotein-1 with fucosylated triantennary N-glycan: a novel colorectal cancer marker.
    Shinozaki E; Tanabe K; Akiyoshi T; Tsuchida T; Miyazaki Y; Kojima N; Igarashi M; Ueno M; Suenaga M; Mizunuma N; Yamaguchi K; Nakayama K; Iijima S; Yamaguchi T
    BMC Cancer; 2018 Apr; 18(1):406. PubMed ID: 29642865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum haptoglobin as a novel molecular biomarker predicting colorectal cancer hepatic metastasis.
    Sun L; Hu S; Yu L; Guo C; Sun L; Yang Z; Qi J; Ran Y
    Int J Cancer; 2016 Jun; 138(11):2724-31. PubMed ID: 26756179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating MIC-1/GDF15 is a complementary screening biomarker with CEA and correlates with liver metastasis and poor survival in colorectal cancer.
    Wang X; Yang Z; Tian H; Li Y; Li M; Zhao W; Zhang C; Wang T; Liu J; Zhang A; Shen D; Zheng C; Qi J; Zhao D; Shi J; Jin L; Rao J; Zhang W
    Oncotarget; 2017 Apr; 8(15):24892-24901. PubMed ID: 28206963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative analysis of TEM-8 and CEA tumor markers indicating free tumor cells in the peripheral blood of colorectal cancer patients.
    Raeisossadati R; Farshchian M; Ganji A; Tavassoli A; Velayati A; Dadkhah E; Chavoshi S; Mehrabi Bahar M; Memar B; Rajabi Mashhadi MT; Naseh H; Forghanifard MM; Moghbeli M; Moaven O; Abbaszadegan MR
    Int J Colorectal Dis; 2011 Oct; 26(10):1265-70. PubMed ID: 21573768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum CNPY2 isoform 2 represents a novel biomarker for early detection of colorectal cancer.
    Peng J; Ou Q; Pan Z; Zhang R; Zhao Y; Deng Y; Lu Z; Zhang L; Li C; Zhou Y; Guo J; Wan D; Fang Y
    Aging (Albany NY); 2018 Aug; 10(8):1921-1931. PubMed ID: 30070972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of circulating serum DNA integrity in colorectal cancer patients.
    Yörüker EE; Özgür E; Keskin M; Dalay N; Holdenrieder S; Gezer U
    Anticancer Res; 2015 Apr; 35(4):2435-40. PubMed ID: 25862911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colorectal carcinoma: nucleosomes, carcinoembryonic antigen and ca 19-9 as apoptotic markers; a comparative study.
    Al-Shuneigat JM; Mahgoub SS; Huq F
    J Biomed Sci; 2011 Jul; 18(1):50. PubMed ID: 21787404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An elevated preoperative serum carbohydrate antigen 19-9 level is a significant predictor for peritoneal dissemination and poor survival in colorectal cancer.
    Takakura Y; Ikeda S; Imaoka Y; Urushihara T; Itamoto T
    Colorectal Dis; 2015 May; 17(5):417-25. PubMed ID: 25512077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of large tenascin-C spliced variant as a potential biomarker for colorectal cancer.
    Takeda A; Otani Y; Iseki H; Takeuchi H; Aikawa K; Tabuchi S; Shinozuka N; Saeki T; Okazaki Y; Koyama I
    World J Surg; 2007 Feb; 31(2):388-94. PubMed ID: 17219282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.
    Fang Z; Tang J; Bai Y; Lin H; You H; Jin H; Lin L; You P; Li J; Dai Z; Liang X; Su Y; Hu Q; Wang F; Zhang ZY
    J Exp Clin Cancer Res; 2015 Aug; 34(1):86. PubMed ID: 26297223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic Value of Serum Concentration and Integrity of Circulating Cell-Free DNA in Breast Cancer: A Comparative Study With CEA and CA15-3.
    Tang Z; Li L; Shen L; Shen X; Ju S; Cong H
    Lab Med; 2018 Oct; 49(4):323-328. PubMed ID: 29701836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.